AI Engines For more Details: Perplexity Kagi Labs You
Pain Relief: Tenoxicam is effective in providing relief from pain caused by conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, gout, and other musculoskeletal disorders.
Anti-inflammatory Effects: As an NSAID, tenoxicam works by inhibiting the production of prostaglandins, which are substances in the body that cause inflammation, swelling, and pain. By reducing inflammation, tenoxicam helps alleviate symptoms associated with inflammatory conditions.
Fever Reduction: Tenoxicam may also help reduce fever by lowering elevated body temperature resulting from inflammation or infection.
Dosage and Administration: Tenoxicam is typically taken orally in the form of tablets or capsules. The dosage prescribed by a healthcare provider may vary depending on the patient's age, medical condition, and response to treatment. It is usually taken once daily with food to minimize the risk of gastrointestinal side effects.
Gastrointestinal Effects: Like other NSAIDs, tenoxicam can cause gastrointestinal side effects such as nausea, indigestion, heartburn, stomach pain, diarrhea, and gastrointestinal ulcers or bleeding. To reduce the risk of these side effects, tenoxicam should be taken with food or antacids, and patients with a history of gastrointestinal problems should use it cautiously.
Cardiovascular Risks: Long-term use of NSAIDs, including tenoxicam, may increase the risk of cardiovascular events such as heart attack or stroke. Patients with pre-existing cardiovascular conditions or risk factors should use tenoxicam with caution and under the supervision of a healthcare provider.
Renal Effects: NSAIDs, including tenoxicam, can affect kidney function and may lead to kidney damage or renal failure, especially in patients with pre-existing kidney disease, dehydration, or conditions that affect renal blood flow. Patients should stay hydrated while taking tenoxicam and monitor for signs of kidney dysfunction.
Hepatic Effects: Tenoxicam may cause liver damage or liver function abnormalities in some individuals. Patients with liver disease or impaired liver function should use tenoxicam cautiously and undergo regular monitoring of liver function tests.
Allergic Reactions: Some individuals may experience allergic reactions to tenoxicam, including rash, itching, swelling, difficulty breathing, and anaphylaxis. Patients with a known allergy to NSAIDs should avoid using tenoxicam.
Drug Interactions: Tenoxicam may interact with other medications, including blood thinners, diuretics, ACE inhibitors, and lithium, potentially increasing the risk of adverse effects or reducing the efficacy of these drugs. Patients should inform their healthcare provider about all medications they are taking before starting tenoxicam therapy.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia hansenii | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Lactococcus cremoris | Reduces |
species | Lactococcus lactis | Reduces |
species | Parabacteroides distasonis | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Parolsenella | genus | Decreases |
0 | 1 | Flavonifractor | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Flavonifractor plautii | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Streptococcus lactarius | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Hungatella hathewayi | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Bacteroides caecimuris | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Streptococcus salivarius | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Streptococcus australis | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Enterocloster clostridioformis | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Streptococcus infantis | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 061 | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Parafannyhessea umbonata | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
0 | 1 | Barnesiella viscericola | species | Decreases |
0 | 1 | Amedibacterium intestinale | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Streptococcus oralis | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Gordonibacter urolithinfaciens | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Anaerostipes caccae | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Blautia hansenii | species | Decreases |
0 | 1 | Anaerostipes rhamnosivorans | species | Decreases |
0 | 1 | Blautia producta | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Streptococcus vestibularis | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Arabiibacter massiliensis | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Lactococcus lactis | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.6 | 0.6 | |
Acne | 0.4 | -0.4 | |
ADHD | 3.1 | 0.6 | 4.17 |
Age-Related Macular Degeneration and Glaucoma | 0.4 | 0.2 | 1 |
Allergic Rhinitis (Hay Fever) | 2.1 | 3.2 | -0.52 |
Allergies | 6 | 1.5 | 3 |
Allergy to milk products | 1.7 | 1.3 | 0.31 |
Alopecia (Hair Loss) | 1.5 | 1.5 | |
Alzheimer's disease | 3.8 | 4.6 | -0.21 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.8 | 0.7 | 1.57 |
Ankylosing spondylitis | 4.1 | 0.4 | 9.25 |
Anorexia Nervosa | 1.3 | 1.6 | -0.23 |
Antiphospholipid syndrome (APS) | 1.4 | 0 | 0 |
Asthma | 3.9 | 2 | 0.95 |
Atherosclerosis | 2.1 | 0.6 | 2.5 |
Atrial fibrillation | 2.7 | 1.5 | 0.8 |
Autism | 5.9 | 6.3 | -0.07 |
Autoimmune Disease | 1.1 | 0.5 | 1.2 |
Barrett esophagus cancer | 0.4 | 0.2 | 1 |
benign prostatic hyperplasia | 0.5 | 0.3 | 0.67 |
Biofilm | 1.8 | 1.8 | |
Bipolar Disorder | 1.2 | 0.9 | 0.33 |
Brain Trauma | 1.2 | 0.9 | 0.33 |
Breast Cancer | 0.6 | 0.6 | |
Cancer (General) | 0.6 | 2.2 | -2.67 |
Carcinoma | 2.8 | 2.2 | 0.27 |
Celiac Disease | 2.4 | 2.9 | -0.21 |
Cerebral Palsy | 1.3 | 0.9 | 0.44 |
Chronic Fatigue Syndrome | 4.4 | 5.3 | -0.2 |
Chronic Kidney Disease | 3.7 | 1.5 | 1.47 |
Chronic Lyme | 0.6 | 0.4 | 0.5 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.3 | 1 | 1.3 |
Chronic Urticaria (Hives) | 1.5 | 0.1 | 14 |
Coagulation / Micro clot triggering bacteria | 1.5 | 0.8 | 0.88 |
Cognitive Function | 1.8 | 0.9 | 1 |
Colorectal Cancer | 4.4 | 2 | 1.2 |
Constipation | 0.9 | 0.5 | 0.8 |
Coronary artery disease | 2.1 | 2.3 | -0.1 |
COVID-19 | 8.4 | 8.6 | -0.02 |
Crohn's Disease | 5.4 | 3.3 | 0.64 |
Cushing's Syndrome (hypercortisolism) | 0.3 | -0.3 | |
cystic fibrosis | 0.9 | 1.8 | -1 |
d-lactic acidosis (one form of brain fog) | 0.7 | 0.7 | |
deep vein thrombosis | 1.6 | 0.7 | 1.29 |
Denture Wearers Oral Shifts | 1 | 1 | |
Depression | 8.5 | 6.5 | 0.31 |
Dermatomyositis | 0.2 | 0.4 | -1 |
Eczema | 1.1 | 1.5 | -0.36 |
Endometriosis | 3.1 | 1.7 | 0.82 |
Eosinophilic Esophagitis | 0.6 | -0.6 | |
Epilepsy | 3.1 | 1.4 | 1.21 |
erectile dysfunction | 0.8 | 0.4 | 1 |
Fibromyalgia | 2.2 | 1.3 | 0.69 |
Functional constipation / chronic idiopathic constipation | 4.2 | 2.8 | 0.5 |
gallstone disease (gsd) | 2.3 | 0.5 | 3.6 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.5 | 1.5 | -2 |
Generalized anxiety disorder | 2.4 | 1.9 | 0.26 |
giant cell arteritis | 0 | 0 | |
Glioblastoma | 0.2 | -0.2 | |
Gout | 1.9 | 0.5 | 2.8 |
Graves' disease | 1.7 | 2.6 | -0.53 |
Gulf War Syndrome | 0.9 | 1 | -0.11 |
Halitosis | 0.9 | 0.2 | 3.5 |
Hashimoto's thyroiditis | 2.4 | 1 | 1.4 |
Heart Failure | 3 | 1.3 | 1.31 |
hemorrhagic stroke | 0.4 | 0.4 | |
Hidradenitis Suppurativa | 0.6 | 0.4 | 0.5 |
High Histamine/low DAO | 0.7 | 0.5 | 0.4 |
hypercholesterolemia (High Cholesterol) | 0.8 | 0.8 | |
hyperglycemia | 2 | 1.3 | 0.54 |
Hyperlipidemia (High Blood Fats) | 0.8 | 0.4 | 1 |
hypersomnia | 0.1 | 0.9 | -8 |
hypertension (High Blood Pressure | 3 | 4.4 | -0.47 |
Hypothyroidism | 0.1 | 1.1 | -10 |
Hypoxia | 1.1 | 1.1 | |
IgA nephropathy (IgAN) | 0.8 | 2.9 | -2.62 |
Inflammatory Bowel Disease | 6.2 | 7.1 | -0.15 |
Insomnia | 2.1 | 1.8 | 0.17 |
Intelligence | 1.4 | 1.4 | |
Intracranial aneurysms | 1 | 0.9 | 0.11 |
Irritable Bowel Syndrome | 5.9 | 3 | 0.97 |
ischemic stroke | 3.2 | 1 | 2.2 |
Liver Cirrhosis | 4.9 | 2.6 | 0.88 |
Long COVID | 6.7 | 6.3 | 0.06 |
Low bone mineral density | 0.7 | -0.7 | |
Lung Cancer | 1.1 | 0.9 | 0.22 |
Lymphoma | 0.5 | 0.5 | |
Mast Cell Issues / mastitis | 0.7 | 0.8 | -0.14 |
ME/CFS with IBS | 1 | 2.8 | -1.8 |
ME/CFS without IBS | 0.5 | 1.9 | -2.8 |
membranous nephropathy | 0.2 | 0.2 | |
Menopause | 2.4 | 0.1 | 23 |
Metabolic Syndrome | 5.8 | 4.9 | 0.18 |
Mood Disorders | 8.3 | 5.8 | 0.43 |
multiple chemical sensitivity [MCS] | 0.7 | 0.4 | 0.75 |
Multiple Sclerosis | 4.2 | 3.4 | 0.24 |
Multiple system atrophy (MSA) | 0.7 | 0.9 | -0.29 |
myasthenia gravis | 0.7 | 0.1 | 6 |
neuropathic pain | 0 | 1.5 | 0 |
Neuropathy (all types) | 0.7 | 1 | -0.43 |
neuropsychiatric disorders (PANDAS, PANS) | 1.1 | 1.1 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 4.3 | 4.1 | 0.05 |
NonCeliac Gluten Sensitivity | 1.6 | 0.7 | 1.29 |
Obesity | 7.6 | 4.4 | 0.73 |
obsessive-compulsive disorder | 4.4 | 2.3 | 0.91 |
Osteoarthritis | 1.9 | 1.1 | 0.73 |
Osteoporosis | 1.4 | 1.4 | 0 |
pancreatic cancer | 0.5 | 0.2 | 1.5 |
Parkinson's Disease | 6.3 | 4.2 | 0.5 |
Polycystic ovary syndrome | 4 | 1.9 | 1.11 |
Postural orthostatic tachycardia syndrome | 0 | 0.7 | 0 |
Premenstrual dysphoric disorder | 1.2 | 0.2 | 5 |
primary biliary cholangitis | 0.8 | 0.7 | 0.14 |
Primary sclerosing cholangitis | 2.3 | 2.3 | 0 |
Psoriasis | 3.2 | 1.5 | 1.13 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 5.2 | 3 | 0.73 |
Rosacea | 0.9 | 0.1 | 8 |
Schizophrenia | 5.3 | 2.1 | 1.52 |
scoliosis | 1 | 0.2 | 4 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 2.6 | 2.1 | 0.24 |
Sleep Apnea | 1.7 | 1.2 | 0.42 |
Slow gastric motility / Gastroparesis | 1.4 | 0.4 | 2.5 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.8 | 0.7 | 1.57 |
Stress / posttraumatic stress disorder | 2 | 1.8 | 0.11 |
Systemic Lupus Erythematosus | 2.8 | 1.4 | 1 |
Tic Disorder | 0.5 | 1.3 | -1.6 |
Tourette syndrome | 0.4 | 0.3 | 0.33 |
Type 1 Diabetes | 2.9 | 2.8 | 0.04 |
Type 2 Diabetes | 6.6 | 4.6 | 0.43 |
Ulcerative colitis | 3.8 | 4.1 | -0.08 |
Unhealthy Ageing | 3.2 | 1.3 | 1.46 |
Vitiligo | 1.3 | 1.1 | 0.18 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]